Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autocrine and paracrine effects of MDK promote lymph node metastasis of cervical squamous cell carcinoma. | iScience | 2024 | 39040052 | PubTator, text mining | PubMed |
| Editorial: Trends in neuroimmunology: cross-talk between brain-resident and peripheral immune cells in both health and disease. | Front Immunol | 2024 | 39026666 | PubTator, text mining | PubMed |
| GPC2 promotes prostate cancer progression via MDK-mediated activation of PI3K/AKT signaling pathway. | Funct Integr Genomics | 2024 | 39014225 | PubTator, text mining | PubMed |
| Targeting the CDK7-MDK axis to suppresses irinotecan resistance in colorectal cancer. | Life Sci | 2024 | 39004275 | PubTator, text mining | PubMed |
| Correction: Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancer. | PLoS One | 2024 | 38980851 | PubTator, text mining | PubMed |
| Integrated bulk and single-cell RNA sequencing identifies an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients' prognosis. | PeerJ | 2024 | 38938612 | PubTator, text mining | PubMed |
| Single-cell analysis of a progressive Rosai-Dorfman disease affecting the cerebral parenchyma: a case report. | Acta Neuropathol Commun | 2024 | 38769536 | PubTator, text mining | PubMed |
| Prognostic and diagnostic effects of high serum midkine levels in patients with hepatocellular carcinoma. | Oncol Lett | 2024 | 38736738 | PubTator, text mining | PubMed |
| Midkine promotes renal fibrosis by stabilizing C/EBPβ to facilitate endothelial-mesenchymal transition. | Commun Biol | 2024 | 38714800 | PubTator, text mining | PubMed |
| Identification of immune-related biomarkers for glaucoma using gene expression profiling. | Front Genet | 2024 | 38694874 | PubTator, text mining | PubMed |
| The role of proliferating stem-like plasma cells in relapsed or refractory multiple myeloma: Insights from single-cell RNA sequencing and proteomic analysis. | Br J Haematol | 2024 | 38671576 | PubTator, text mining | PubMed |
| Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis. | EBioMedicine | 2024 | 38614865 | PubTator, text mining | PubMed |
| Mgp High-Expressing MSCs Orchestrate the Osteoimmune Microenvironment of Collagen/Nanohydroxyapatite-Mediated Bone Regeneration. | Adv Sci (Weinh) | 2024 | 38588510 | PubTator, text mining | PubMed |
| Cross-sectional and longitudinal analyses of urinary extracellular vesicle mRNA markers in urothelial bladder cancer patients. | Sci Rep | 2024 | 38514751 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals critical modulators of extracellular matrix of penile cavernous cells in erectile dysfunction. | Sci Rep | 2024 | 38467692 | PubTator, text mining | PubMed |
| Heparin-enriched plasma proteome is significantly altered in Alzheimer's Disease. | Res Sq | 2024 | 38464223 | PubTator, text mining | PubMed |
| Novel Midkine Inhibitor Induces Cell Cycle Arrest and Apoptosis in Multiple Myeloma. | Anticancer Res | 2024 | 38423667 | PubTator, text mining | PubMed |
| Sleep apnoea increases biomarkers of immune evasion, lymphangiogenesis and tumour cell aggressiveness in high-risk patients and those with established lung cancer. | ERJ Open Res | 2024 | 38375428 | PubTator, text mining | PubMed |
| B-cell ALL with SOX11 gene amplification associates with a worse outcome. | Cell Cycle | 2024 | 38350028 | PubTator, text mining | PubMed |
| Elucidation of pericholangitis and periductal fibrosis in cholestatic liver diseases via extracellular vesicles released by polarized biliary epithelial cells. | Am J Physiol Cell Physiol | 2024 | 38344767 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=15